Dennis J. Donohoe, M.D.
Chief Medical Advisor
Dennis Donohoe, M.D. was appointed Chief Medical Advisor at Micell Technologies in 2009. During his tenure, Dennis has designed and managed the DESSOLVE Clinical Program for the MiStent SES.
Dennis is a primary care physician who practiced in the Philadelphia area for five years before joining the industry. He has about 26 years of industry experience in both pharmaceutical and medical/surgical device clinical development. Prior to working with Micell, Dennis worked in various Johnson & Johnson capacities for a total of 20 years. He was the Worldwide Vice President of Clinical, Regulatory and Medical Affairs for Cordis Corporation, the Director of Medical Affairs for Ethicon, Inc. and the Director of Clinical Research at the Pharmaceutical Research Institute. He was with Cordis for 11 years and had responsibility for the clinical development of cardiology, neurovascular and endovascular devices. He also was a board member of the Cordis franchise.
While at Johnson & Johnson, Dennis received the Johnson Medal, the highest scientific award by Johnson & Johnson, in recognition of the clinical development of a topical growth factor for the treatment of chronic wounds. Dennis also served as the Director of Clinical Research in the gastrointestinal therapeutic group at Glaxo for one year.
He received his undergraduate degrees in biology and psychology from LaSalle College in Philadelphia and his medical degree from the Penn State Hershey Medical Center.